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The facile ability of iron to gain and lose electrons has made iron an important participant in a wide variety of biochemical reactions. Binding of ligands to iron modifies its redox potential, thereby permitting iron to transfer electrons with greater or lesser facility. The ability to transfer electrons, coupled with its abundance, as iron is the fourth most abundant mineral in the earth's crust, have contributed to iron being an element required by almost all species in the six kingdoms of life. Iron became an essential element for both Eubacteria and Archeabacteria in the early oxygen-free stages of the earth's evolution. With the advent of an oxygen-rich environment, the redox properties of iron made it extremely useful, as much of iron utilization in eukaryotes is focused on oxygen metabolism, either as an oxygen carrier or as an electron carrier that can facilitate oxygen-based chemistry.
Three major classes of ironcontaining proteins carry out these reactions: iron-sulfur clustercontaining proteins; heme-containing proteins; and iron-containing enzymes that are devoid of iron-sulfur clusters or heme. Examples of iron-containing moieties in these proteins are shown in Figure 1 . Iron-sulfur (Fe-S)-containing proteins are found as independent enzymes that catalyze discrete chemical reactions or as components in complexes that transport electrons. Proteins that bind heme -a complex of iron and protoporphyrin -play a major role in oxygen binding and in the metabolism of oxygen-containing molecules. Finally, iron can bind to proteins independently of Fe-S or heme and those proteins play a major role in diverse metabolic activities. For example, oxo di-iron (Fe-O-Fe) enzymes are widely used for dehydrogenation reactions that utilize molecular oxygen to introduce double bonds. The di-iron center is found in a variety of proteins, including methane monooxygenase, ribonucleotide reductase, and methyl sterol oxidase. The three types of iron-containing protein are found in all biological kingdoms, although depending on the oxygen tension of the environment, heme and oxo di-iron-containing enzymes, which are heavily used in oxygen-based metabolism, may be absent. For example, aerobically growing yeast express all three types of iron-containing proteins, while anaerobically growing yeast only express iron-sulfur cluster-containing proteins. The second approach taken by organisms to acquire iron is to synthesize and secrete small organic molecules termed siderophores, which have a high affinity for Fe 3+ ( Figure  2B ). The affinity of deferoxamine, a siderophore produced by the bacteria Streptomyces pilosus, is reported to be (K d ) 10 -33 M. This affinity is high enough to bind the sparingly soluble Fe 3+ at neutral pH. Specific 
Mechanisms of iron acquisition
Regulation of iron acquisition and utilization
The same properties of electron transfer that make iron so useful in biochemical reactions can result in the generation of toxic oxygen radicals. Thus, the concentration of iron in biological fluids is tightly regulated. This regulation is achieved through the coordinated activities of elemental iron transporters, siderophore biosynthetic enzymes and siderophore transporters. The expression of genes and proteins involved in iron acquisition and storage is regulated by mechanisms extending from transcription to post-translational modifications. Transcription of iron-acquisition systems is regulated by iron availability; transcription is increased by iron scarcity and decreased by iron surplus. Two major metal-sensing transcription factors in bacteria, Fur and Dtx, are primarily transcriptional repressors. The Fur protein binds iron and, to a lesser degree, Mn 2+ and controls the activity of a wide variety of operons by occupying promoters when the protein is metal replete and dissociating from the promoters under conditions of metal deprivation. Binding of metalated Fur to specific DNA sequences in promoters renders these promoters inaccessible to RNA polymerase. There are, however, promoters that are transcriptionally activated by metalated Fur.
In most fungi, a repressor likewise mediates transcriptional regulation of genes involved in iron acquisition. This repressor (Fep1 in Schizosaccharomyces pombe, Sre in Aspergillus nidans) is a member of the family of DNA-binding proteins that recognize GATA as part of their DNA-binding sequence. Under conditions of iron sufficiency, these proteins bind to target sequences, resulting in transcriptional repression. Iron scarcity induces the dissociation of the repressor from promoters permitting transcription. Transcription of iron-acquisition genes in S. cerevisiae and related yeast is controlled by two paralogous transcription activators Aft1 and Aft2. From available data, it has been suggested that both fungal transcription activators and repressors may not sense iron directly but rather sense Fe-S clusters. Defects in Fe-S cluster synthesis result in induction of the iron regulon independent of the concentration of cytosolic iron.
Transcription of many genes involved in iron utilization is coregulated with genes required for oxygen metabolism. The key regulators of the response to hypoxia in vertebrates are cytosolic proteins termed hypoxia inducible factors (HIFs). These proteins (HIF1 and HIF2) are synthesized in the cytosol where they are substrates for prolyl hydroxylases, which are Fe 2+ -containing enzymes. Hydroxylation requires a mitochondrially produced substrate, oxo-glutarate, and oxygen. Prolyl hydroxylation of HIF results in its recognition by ubiquitin ligases leading to HIF ubiquitination and degradation by the proteosome. Decreased oxygen tension or iron scarcity inhibits prolyl hydroxylation, resulting in the accumulation of HIF1/HIF2. Accumulated HIF1/HIF2 is then a component of a transcription factor that regulates genes involved in iron acquisition, energy metabolism and oxygen transport. For example, HIF1 promotes the production of erythropoietin, increasing the production of red blood cells, which are the greatest 'consumers' of iron.
The coordinated expression of genes involved in iron utilization with genes involved in iron acquisition is a common theme for all organisms. The same transcription factors (or post-transcriptional regulators) that regulate the acquisition of iron also regulate changes in iron utilization. Under conditions of iron scarcity, metabolic reactions are rearranged to be iron sparing. For example, during iron scarcity E. coli stops transcription of iron-superoxide dismutase in favor of manganese-containing superoxide dismutase. Similarly, under ironlimiting conditions S. cerevisiae decreases respiratory metabolism, which utilizes heme and iron-sulfur cluster-containing proteins, in favor of fermentative metabolism, which utilizes fewer iron-containing proteins.
Regulation of iron storage
Invariably, changes in iron acquisition are accompanied by changes in iron storage; increased acquisition is coupled to decreased storage and vice versa. Organisms use either of two strategies to store iron. The first strategy is to bind iron in a form that prevents it from participating in biochemical reactions. Bacteria, invertebrates and vertebrates synthesize proteins termed ferritins, which bind Fe 2+ and oxidize it to Fe 3+ , in combination with oxygen and phosphate. The stored ferric iron is essentially unreactive and will not participate in oxidation-reduction reactions. Mammalian ferritins have an extraordinary capacity to store iron. Twelve ferritin monomers assemble to form a shell that can store up to 4,500 iron atoms. Iron can be recovered from ferritin for cellular use, although that mechanism is not well defined. Plants and fungi do not express cytosolic ferritin; rather they store iron in the vacuole, which is a lysosome-like organelle (although plants do contain ferritin in plastids such as chloroplasts). In yeast and plants a homologous transporter (Ccc1 and VIT1, respectively) mediates entry of iron into vacuoles. In S. cerevisiae the iron-responsive transcriptional activator Yap5 regulates CCC1 expression. Iron storage is coordinated with iron acquisition because Fe-S clusters also regulate Yap5 transcription. The absence of Fe-S clusters induces the low-iron transcriptional response and prevents the high-iron transcriptional response. Iron can be transported from the vacuole to the cytosol by transporters that are homologues of cell-surface elemental iron transporters. In yeast these transporters are regulated by the same transcription factors as the cellsurface transporters. This regulation is designed to increase cytosolic iron by acquiring iron from either internal stores or the external environment.
Vertebrates also coordinate iron acquisition with iron storage. The best-defined mechanism is through post-transcriptional regulation. Many of the mRNAs that encode proteins required for iron acquisition and storage contain stem-loop structures, termed iron regulated elements (IREs), in either the 5' or 3' untranslated regions. These regions are capable of binding specific proteins termed iron-regulated proteins (IRPs) 1 or 2. Binding of IRPs to the IRE is iron sensitive and the proteins bind to the IRE under low cytosolic iron conditions. Binding of IRPs to mRNA containing 3' IREs protects mRNA from degradation, while binding of IRPs to 5' IRE-containing mRNA prevents translation (Figure 3) . Following depletion of cytosolic iron, the translation of the 5' IRE-containing Figure 3 . Post-transcriptional regulation of the expression of proteins required for iron acqisition and storage. Many mRNAs encoding proteins involved in iron metabolism contain iron regulatory elements (IREs) in their 5' or 3' UTRs. When cytosolic iron is low, iron regulatory proteins (IRPs) bind to the 5' IRE thereby preventing translation (in the case of ferritin or Fpn1) or to the 3' IRE thereby stabilizing mRNA (as seen for TfR1 or DMT1). When cytosolic iron is high, IRPs are inactive and no longer bind IREs, allowing for either translation (ferritin or Fpn1) or mRNA degradation (TfR or DMT1).
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mRNA for the iron storage protein ferritin or the iron exporter ferroportin is prevented. At the same time translation of the 3' IRE-containing mRNAs encoding the iron transporter divalent metal transporter 1 (DMT1) and transferrin receptor 1 (TfR1) is not affected, permitting cellular iron accumulation. When cytosolic iron concentrations increase, the IRPs are released from the IREs, so that translation of mRNAs that mediate iron storage or export is increased, while translation of mRNAs that effect iron acquisition is reduced due to increased mRNA turnover. The IRPs are regulated differently by iron. In iron-deficient conditions IRP1 is an RNA-binding molecule but under iron sufficiency IRP1 gains a 4Fe-4S cluster and becomes an active aconitase. The presence of the 4Fe-4S cluster prevents IRP1 from binding to mRNA. IRP2, on the other hand, is degraded under high iron conditions through ubiquitinmediated proteosomal degradation. The turnover of the ubiquitin ligase responsible for IRP2 ubiquitination is itself regulated by iron, such that iron promotes accumulation of the ligase, thus leading to the ubiquitination and degradation of IRP2.
Mechanism and regulation of iron transport into organelles
Mitochondria are the site of synthesis for heme and Fe-S clusters, which are not only used in mitochondria but are exported to the cytosol and to other subcellular organelles. Iron entry into mitochondria is mediated by transporters that belong to the large family of mitochondrial carrier facilitators. These transporters have six transmembrane domains, are located in the inner mitochondrial membrane and are primarily anion antiporters. Two homologous transporters, Mrs3 and Mrs4, mediate iron transport in S. cerevisiae, and highly homologous proteins termed mitoferrins mediate mitochondrial iron transport in plants, invertebrates and vertebrates. Yeast and vertebrates contain two mitoferrins, although other species such as Oryza (rice) and Drosophila have only one. In vertebrates Mitoferrin1 and Mitoferrin2 are regulated differently. Mitoferrin1 is highly expressed in developing red blood cells, a cell which is specialized for heme synthesis, while Mitoferrin2 seems to be ubiquitously expressed. The increased expression of Mitoferrin1 in developing red blood cells is an adaptation for the high rate of heme synthesis required for hemoglobin accumulation. Transcriptional and post-transcriptional regulatory mechanisms ensure that mitochondria express high levels of Mitoferrin1 at the same time as they increase their synthesis of porphyrins, the other component of heme. Pic1, a four transmembrane domain-containing protein localized in the chloroplast membrane, mediates iron entry. The closest homologues to Pic1 are permeases in cyanobacteria, perhaps reflecting the evolutionary history of chloroplasts.
Regulation of iron distribution within eukaryotes
Multicellular organisms need to distribute iron from the site of absorption to the sites of usage or storage. This necessitates mechanisms to absorb iron from the environment and to export that iron from absorptive cells to cells that can utilize or store it (Figure 4) Figure 4 . Vertebrate systemic iron homeostasis. Total body iron in humans is about 3-4 g: 1-2 mg/day of iron is absorbed in the duodenum. Iron is then transported into plasma where it is bound to transferrin (Tf). Tf-Fe is delivered to developing tissues and erythrocytes. Aged erythrocytes are phagocytosed by macrophages, hemoglobin broken down, and iron (20-30 mg/day) transported back to plasma. When the amount of iron exceeds Tf-binding capacity, iron is deposited in parenchymal tissues (e.g. liver).
Tf(Fe 3+ ) is recognized by specific cell-surface Tf receptors (TfRs), which bind it with high affinity ( Figure 5 ). The Tf(Fe 3+ ) 2 -TfR complex is internalized into an intracellular compartment (endosome). This compartment has an acidic pH resulting from the action of an ATPdriven H + pump. The compartment also contains a membrane-bound reductase (identified in red blood cell precursors as Steap3), and the iron transporter DMT1. The combination of low pH, binding of Tf to the TfR and reduction of Fe 3+ to Fe 2+ contribute to the dissociation of iron from Tf. Fe 2+ can now be transported by DMT1 from the endosome to the cytosol. ApoTf remains bound to the receptor at the low pH of the endosome but dissociates from the receptor at the neutral pH of blood. Released apoTf can now bind iron and restart the iron cycle. The binding of iron to apoTf ensures iron delivery to those cell types that need it most. Cells that need iron show increased expression of TfRs, resulting from transcriptional and post-transcriptional regulatory mechanisms.
When the binding capacity of apoTf is exceeded by iron entering the blood, non-Tf-bound iron is cleared by parenchymal cells, such as hepatocytes in the liver. Iron stored within hepatocytes can be reutilized in times of need. Thus, a major problem faced by vertebrates is the coordination of iron entry into blood with iron utilization and storage. Vertebrates have solved this problem through the expression of the small peptide hepcidin, which is a negative regulator of iron acquisition. Hepcidin can be synthesized by a number of cell types, including hepatocytes and macrophages. Hepcidin synthesis is increased by iron overload and inflammation and is decreased by iron demand, erythropoiesis and hypoxia. Hepcidin binds to ferroportin and induces ferroportin internalization and degradation. The removal of ferroportin from cell surfaces prevents cellular iron export, while the absence of hepcidin results in increased cellsurface ferroportin and increased iron entry into blood. Mutations that affect hepcidin levels may result in disease. Increased hepcidin levels lead to decreased iron absorption, which if persistent will result in the production of iron-deficient red blood cells and anemia. Conversely, decreased hepcidin levels result in increased iron absorption and, if prolonged, can lead to iron overload disorders.
Concluding remarks
The dual nature of iron -both its essential nature and potentially toxic properties -have resulted in the evolution of mechanisms to acquire iron and to regulate its concentration in biological fluids. While there are many examples of species-specific adaptations to deal with the iron conundrum, it is interesting to note that many of the transporters (DMT1/NRAMP1, Mrs/mitoferrin) that evolved to effect iron transfer across membranes have been conserved throughout evolution. Similarly, enzymes that utilize iron or synthesize iron-containing molecules (Fe-S clusters) have been conserved from bacteria to humans. These examples of conservation provide evidence for the early evolutionary development of iron utilization and the considerable efforts required to safely acquire this element. Figure 5 . Tf-TfR1-mediated cellular iron uptake. Tf-Fe binds to the TfR1 on the plasma membrane and is internalized by endocytosis. The pH within the endosome drops due to H + import, allowing Fe 3+ to dissociate from Tf. Fe 3+ is reduced by Steap3 and Fe 2+ is transported from endosome to cytosol by DMT1. Iron-free Tf is recycled back to the cell surface where it is released at neutral pH and can rebind plasma Fe 3+ .
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